Meibomian gland dysfunction patients benefit in ocular parameters and tear chemokines after thermal pulsation treatment.
Meibomian gland dysfunction patients benefit in ocular parameters and tear chemokines after thermal pulsation treatment.
复制标题
DOI:
10.7150/ijms.76603
复制
发表时间:
2023
影响因子:
3.6
通讯作者:
Gong L
中科院分区:
文献类型:
--
作者:
Liu W;Lin T;Gong L
Objectives: To investigate the effect of thermal pulsation treatment on meibomian gland function, ocular parameters and tear inflammatory cytokines compared with the warm compress group. Methods: Twenty-five participants with MGD underwent a 12-minute thermal pulsation treatment, while 25 participants with MGD underwent manual warm compress treatment. MGD related parameters, including meibomian gland function (MGE, MQ and lid margin), tear stability (NIKBUT, FBUT and LLT), tear secretion (SIT, and TMH), were examined and OSDI questionnaire was also obtained. Tear chemokines (MIG, IFN-γ, IL-8, IP-10 and MCP-1) were examined and analyzed the correlations with MGD related parameters and OSDI. Results: Compared with warm compress subjects, OSDI, lid margin and tear stability were found improved more in thermal pulsation treatment at 3 months (OSDI: *p = 0.014, lid margin: *p = 0.021, LLT: **p = 0.008, CFS: *p = 0.028). The level of IP-10 and MIG decreased more in thermal pulsation group than in warm compress group (IP-10: *p = 0.021, MIG: *p = 0.039). IP-10 was positively correlated with MQ (r = 0.522, *p = 0.037) and negatively correlated with tear stability (r = -0.613, **p = 0.002), and OSDI was only positively correlated with IL-8 (r = 0.679, ***p < 0.001). The decrease of MIG was positively correlated with less corneal epithelium injury (r = 0.557, **p = 0.006) and meibograde (r = 0.49, *p = 0.019). Conclusions: Thermal pulsation treatment obviously improved MGD probably by attenuating tear CXCL chemokines in ocular surface of MGD patients, which demonstrated an efficacy and well-tolerated therapy in clinical.
登录
查看更多内容
DOI:
10.2147/opth.s153297
发表时间:
2018
期刊:
Clinical ophthalmology (Auckland, N.Z.)
影响因子:
--
作者:
Blackie CA;Coleman CA;Nichols KK;Jones L;Chen PQ;Melton R;Kading DL;O'Dell LE;Srinivasan S
通讯作者:
Srinivasan S
影响因子:
5.9
作者:
Park, Bongkyun;Jo, Kyuhyung;Kim, Chan-Sik
通讯作者:
Kim, Chan-Sik
影响因子:
1.4
作者:
Gao, Yu-Fei;Liu, Rong-Jun;Qi, Hong
通讯作者:
Qi, Hong
DOI:
10.2147/opth.s109663
发表时间:
2016
期刊:
Clinical ophthalmology (Auckland, N.Z.)
影响因子:
--
作者:
Blackie CA;Coleman CA;Holland EJ
通讯作者:
Holland EJ
影响因子:
6.4
作者:
Craig, Jennifer P.;Nelson, J. Daniel;Sullivan, David A.
通讯作者:
Sullivan, David A.